Partner Brent Babcock was quoted in, “Trump PTO Pick Gets Boost From IP Bar, Patent Lobbies,” an article published in The Recorder. Excerpt: President Donald Trump’s choice to lead the U.S. Patent and Trademark…
Knobbe Martens is pleased to announce that partners Salima Merani, Ph.D., Susan Natland, Joseph Re, John Sganga, and Sheila Swaroop have been selected by the Daily Journal for inclusion in…
Partner Brent Babcock was quoted in “There May Still Be Hope For Assignor Estoppel At The PTAB,” an article published in Law360. Excerpt: The Patent Trial and Appeal Board’s recent decision to…
Knobbe Martens is pleased to announce that David Weiss, Managing Partner of the Los Angeles office, has been named to the Los Angeles Business Journal’s “Most Influential IP Attorneys” list….
Knobbe Martens is pleased to announce that eighteen partners, including Maria Anderson, Fred Berretta, Bill Bunker, John M. Carson, Joseph Cianfrani, Joseph Jennings, Steven Nataupsky, Carol Pitzel Cruz, Joseph Re,…
Partner Brent Babcock was interviewed in “Biopharmas Should Stay Course as High Court Mulls Patent Reviews,” an article published in Bloomberg BNA. Excerpt: The U.S. Supreme Court is set to rule in…
Partner Jeff Van Hoosear was quoted in “The ‘Wrinkle’ in Trademark Law Used to Keep Filings a Secret,” an article published in Corporate Counsel. Excerpt: A U.S. trademark law provision is being…
Partner Eric Furman was quoted in “Plant breeders test-drive first open-source seed bank,” an article published in Nature Biotechnology. Excerpt: Under the OpenSourceSeed initiative, agricultural scientists can access opensource seeds, by paying…
Knobbe Martens, one of the nation’s leading intellectual property law firms, recently announced that senior partner Gerard von Hoffmann has relocated from Irvine to the firm’s San Diego office in…
Partner Brent Babcock was quoted in “Us Supreme Court Case Could End Patent Office Reexaminations Procedure,” an article published in Medtech Insight. Excerpt: IPRs have become an increasingly common approach in medtech…